Fig. 7: MYH9761-768 immunization enhances antigen-specific response in the CNS of mice with EAE.

C57BL/6 mice, immunized with 100 µg MOG35-55, admixed with OVA257-264 (n = 10) or with MYH9761-768 (n = 9), were sacrificed at day 29. A Splenocytes were challenged ex vivo for 48 hr with the indicated stimuli and IFN-γ was measured in the supernatants through ELISA. Bars represent means ± SEM. *P < 0.05, ***P < 0.005, by Mann–Whitney test. B Representative stainings of OVA257-264-specific (blue) or MYH9761-768-specific (red) cells in CD8+ T cells from SPL or CNS of mice immunized with MOG35-55 plus the indicated peptides. Right plots show CD44/CD49d expression in gated antigen-specific or total (gray) cells. C Cumulative analysis of the percentage of OVA257-264-specific (left plots) or MYH9761-768-specific (right plots) cells in CD8+ T cells from SPL or CNS of mice immunized with MOG35-55 plus OVA257-264 (blue) or MYH9761-768 (red). The data are from a single experiment representative of two independent experiments. Bars represent means ± SEM.